Autism: Is This a Vascular Disease and Would Therapeutic Angiogenesis Be a Potential Treatment?
15 août 2023 08h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Dr. Jack Jacobs, Chief Science Officer of Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), will be presenting at the online AutismOne...
Zhittya Genesis Medicine announces: Free Zoom Webinar: Zhittya Parkinson’s Disease Research Study: 6-Month Patient Follow-Up Report
19 déc. 2022 12h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that they will be hosting a webinar on Tuesday, December 20, 2022, at 4:00 PM...
Zhittya Genesis Medicine - Parkinson’s Disease and Other Brain Disorders: Is FGF-1 a Novel Breakthrough Medical Treatment
25 oct. 2022 10h00 HE
|
Zhittya Genesis Medicine Inc
Invitation to a Free Luncheon Presentation in Jeddah, Saudi Arabia, on Monday, October 31, 2022, at 1:00 pm (13:00) View Preliminary Human Data after 30 Days Treatment of Parkinson’s Disease Patients...
Zhittya Genesis Medicine announces: Free Zoom Webinar: Parkinson’s Disease Sufferers Motor Skills Improve by 50% After Medical Research Study
21 juin 2022 10h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 21, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that they will be hosting a webinar on June 23, 2022 at 3:00 PM Pacific Time...
Zhittya Genesis Medicine Announces: Parkinson’s Disease Sufferers Motor Skills Improved by 50% After Medical Research Study
16 juin 2022 14h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 16, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that the human test subjects in its first-in-human research study for the...
Zhittya Genesis Medicine Completes its First-In-Human Study with a Novel Intranasal Treatment for Parkinson’s Disease
08 juin 2022 11h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 08, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it has completed its first-in-human research study for the treatment of...
Zhittya Genesis Medicine-Parkinson’s Disease-Free Webinar for its Clinical Trial to treat Parkinson’s Disease
26 janv. 2022 10h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of...
Zhittya Genesis Medicine Starts ALS/Motor Neuron Disease Clinical Trial
18 janv. 2022 11h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for the treatment of...
Zhittya Genesis Medicine Starts Parkinson’s Disease Clinical Trial
12 janv. 2022 11h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya”), announced that it is starting a “Compassionate Use Clinical Trial” for treatment of...
Mr. Daniel C. Montano, CEO, is recognized as Biotech Entrepreneur of the Year and Dr. Marc Kahn as Medical Professional of the Year by the Nevada Biotechnology & Health Science Consortium
17 juin 2021 13h00 HE
|
Zhittya Genesis Medicine Inc
LAS VEGAS, June 17, 2021 (GLOBE NEWSWIRE) -- Zhittya Genesis Medicine, Inc. (a private company) (“Zhittya” or the “Company”), is proud to announce that Mr. Daniel C. Montano, CEO, and founder of...